PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design

[1]  D. Katritsis.  Abstracts of the Annual Spring Meeting 2017 of the European Congenital Heart Surgeons Association, Leicester, UK, 19-20th May, 2017 , 2017, Cardiology in the Young.

[2]  A. Zwinderman,et al.  Prevention of Sudden Cardiac Death in Adults With Congenital Heart Disease: Do the Guidelines Fall Short? , 2017, Circulation. Arrhythmia and electrophysiology.

[3]  B. Mulder,et al.  Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis. , 2016, European heart journal.

[4]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[5]  John K. Triedman,et al.  PACES/HRS Expert Consensus Statement on the Recognition and Management of Arrhythmias in Adult Congenital Heart Disease: Executive Summary , 2014 .

[6]  Nandini Dendukuri,et al.  Lifetime Prevalence of Congenital Heart Disease in the General Population From 2000 to 2010 , 2014, Circulation.

[7]  J. López-Sendón,et al.  Incidence and predictors of sudden cardiac arrest in adults with congenital heart defects repaired before adult life. , 2012, The American journal of cardiology.

[8]  M. Woodward,et al.  Risk prediction models: II. External validation, model updating, and impact assessment , 2012, Heart.

[9]  I. V. Van Gelder,et al.  Sudden Cardiac Death in Adult Congenital Heart Disease , 1996, Circulation.

[10]  J. Roos‐Hesselink,et al.  Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. , 2011, Journal of the American College of Cardiology.

[11]  D. Grobbee,et al.  Mortality in adult congenital heart disease. , 2010, European heart journal.

[12]  Yvonne Vergouwe,et al.  Prognosis and prognostic research: validating a prognostic model , 2009, BMJ : British Medical Journal.

[13]  Stephen L Moore,et al.  Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. , 2008, Journal of the American College of Cardiology.

[14]  H. Sairanen,et al.  Causes of late deaths after pediatric cardiac surgery: a population-based study. , 2007, Journal of the American College of Cardiology.

[15]  B. Mulder,et al.  CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: Rationale, design, and first results , 2005, European Journal of Epidemiology.

[16]  Douglas L Packer,et al.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. , 2005, The New England journal of medicine.

[17]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[18]  S. Siu,et al.  Mode of death in adults with congenital heart disease. , 2000, The American journal of cardiology.